A Study in Type 2 Diabetic Subjects of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Compound (GPR111598)

Authors

Jeffrey L. Huston, Cedarville UniversityFollow

Role

Lead Pharmacist

Sponsor

GlaxoSmithKline

Location

Brentford, England

Recommended Citation

Huston, Jeffrey L., "A Study in Type 2 Diabetic Subjects of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Compound (GPR111598)" (2009). Pharmacy Faculty Research. 3.
https://digitalcommons.cedarville.edu/pharmacy_research/3